BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11149743)

  • 1. Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia.
    Howrey RP; Martin PL; Driscoll T; Szabolcs P; Kelly T; Shpall EJ; Bearman SI; Slat-Vasquez V; Rubinstein P; Stevens CE; Kurtzberg J
    Bone Marrow Transplant; 2000 Dec; 26(11):1251-4. PubMed ID: 11149743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of related and unrelated umbilical cord blood stem cells in Austria. Austrian Working Party for Stem Cell Transplantation. Austrian Society of Hematology and Oncology.
    Schwinger W; Urban C; Lackner H; Kerbl R; Sovinz P; Gardner H; Peters C; Niederwieser D; Fink FM; Kögler G
    Wien Klin Wochenschr; 1999 May; 111(9):348-53. PubMed ID: 10407995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation.
    Kurtzberg J; Graham M; Casey J; Olson J; Stevens CE; Rubinstein P
    Blood Cells; 1994; 20(2-3):275-83; discussion 284. PubMed ID: 7749107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Graft-versus-leukemia effect by lymphocytes from the first donor after second cord blood transplantation in a patient with T-lymphoblastic lymphoma].
    Nagai K; Hashimoto H; Itoh K; Matsushita A; Shimoji S; Kimura T; Inoue D; Mori M; Nagai Y; Tabata S; Yanagida M; Takahashi T
    Rinsho Ketsueki; 2010 Jun; 51(6):413-21. PubMed ID: 20622488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
    Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
    Ota K; Hashino S; Shimizu K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Imamura M; Asaka M
    Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
    Kuroki F; Goto H; Yanagimachi M; Kajiwara R; Fujii H; Isaki S; Takahashi H; Ikuta K; Yokota S
    Rinsho Ketsueki; 2006 Jul; 47(7):639-44. PubMed ID: 16910574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute lymphoblastic leukemia in childhood treated with non-T-cell depleted bone marrow transplantation from an HLA 2 loci (HLA-A and-DRB1)-mismatched mother after early graft failure of cord blood transplantation].
    Ishida H; Mori K; Yoshihara T; Shin N; Morimoto A; Imashuku S
    Rinsho Ketsueki; 2003 Nov; 44(11):1101-6. PubMed ID: 14689875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
    J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Unrelated umbilical cord blood transplantation as a treatment for children with malignant leukemia].
    Tang XF; Luan Z; Xu SX; Wu NH; Huang YZ; Wang K
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):5-8. PubMed ID: 18289460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Limited but potential efficacy by graft-versus-leukemia (GVL) for Pro T-ALL].
    Imataki O; Koike A; Iwabu M; Shintani T; Waki F; Ohue Y; Ohnishi H; Ishida T
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1911-4. PubMed ID: 19011341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-haploidentical umbilical cord blood stem cell transplantation in a child with advanced leukemia: clinical outcome and analysis of hematopoietic recovery.
    Miniero R; Busca A; Roncarolo MG; Saitta M; Iavarone A; Timeus F; Biondi A; Amoroso A; Perugini L; Ciuti E
    Bone Marrow Transplant; 1995 Aug; 16(2):229-40. PubMed ID: 7581141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia.
    Lee JH; Choi SJ; Lee JH; Seol M; Lee YS; Ryu SG; Park CJ; Chi HS; Lee MS; Yun S; Lee JS; Lee KH
    Haematologica; 2005 Oct; 90(10):1380-8. PubMed ID: 16219575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-leukemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia: significantly lower relapse rate in unrelated transplantations.
    Gassas A; Sung L; Saunders EF; Doyle J
    Bone Marrow Transplant; 2007 Nov; 40(10):951-5. PubMed ID: 17873916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.